Activation of PPARα by Wy-14643 ameliorates systemic lipopolysaccharide-induced acute lung injury

Biochemical and Biophysical Research Communications

Volumn 436, Issue 3, 2013, Pages 366-371

  Yoo, Seong Ho ^a   Abdelmegeed, Mohamed A ^b   Song, Byoung Joon ^b  

^a Seoul National University College of Medicine   (South Korea)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Acute lung injury; Cytokines; Lipopolysaccharide; Nitroxidative stress; Peroxisome proliferator activated receptor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; FEMALE; HISTOPATHOLOGY; IN VIVO STUDY; LUNG PARENCHYMA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; THERAPY EFFECT; WILD TYPE;

ACUTE LUNG INJURY; ALI; CYTOKINES; LIPOPOLYSACCHARIDE; LPS; MALONDIALDEHYDE; MDA; NITROXIDATIVE STRESS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-Α; PPARΑ; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1; STAT1;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-6; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; LUNG; MICE; OXIDATIVE STRESS; PNEUMONIA; PPAR ALPHA; PYRIMIDINES;

MUS;

EID: 84879888063     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.073     Document Type: Article

References (18)

1. Rubenfeld G.D., Caldwell E., Peabody E., Weaver J., Martin D.P., Neff M., Stern E.J., Hudson L.D. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 2005, 353:1685-1693.
2. Chen H., Bai C., Wang X. The value of the lipopolysaccharide-induced acute lung injury model in respiratory medicine. Expert Rev. Respir. Med. 2010, 4:773-783.
3. Francis G.A., Fayard E., Picard F., Auwerx J. Nuclear receptors and the control of metabolism. Annu. Rev. Physiol. 2003, 65:261-311.
4. Delerive P., De Bosscher K., Vanden Berghe W., Fruchart J.C., Haegeman G., Staels B. DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha. Mol. Endocrinol. 2002, 16:1029-1039.
5. Larter C.Z., Yeh M.M., Van Rooyen D.M., Brooling J., Ghatora K., Farrell G.C. Peroxisome proliferator-activated receptor-alpha agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis. J. Gastroenterol. Hepatol. 2012, 27:341-350.
6. Lee J.H., Joe E.H., Jou I. PPAR-alpha activators suppress STAT1 inflammatory signaling in lipopolysaccharide-activated rat glia. Neuroreport 2005, 16:829-833.
7. Yoo S.H., Park O., Henderson L.E., Abdelmegeed M.A., Moon K.H., Song B.J. Lack of PPARalpha exacerbates lipopolysaccharide-induced liver toxicity through STAT1 inflammatory signaling and increased oxidative/nitrosative stress. Toxicol. Lett. 2011, 202:23-29.
8. Schaefer M.B., Pose A., Ott J., Hecker M., Behnk A., Schulz R., Weissmann N., Gunther A., Seeger W., Mayer K. Peroxisome proliferator-activated receptor-alpha reduces inflammation and vascular leakage in a murine model of acute lung injury. Eur. Respir. J. 2008, 32:1344-1353.
9. Murakami K., McGuire R., Cox R.A., Jodoin J.M., Bjertnaes L.J., Katahira J., Traber L.D., Schmalstieg F.C., Hawkins H.K., Herndon D.N., Traber D.L. Heparin nebulization attenuates acute lung injury in sepsis following smoke inhalation in sheep. Shock 2002, 18:236-241.
10. Anderson S.P., Howroyd P., Liu J., Qian X., Bahnemann R., Swanson C., Kwak M.K., Kensler T.W., Corton J.C. The transcriptional response to a peroxisome proliferator-activated receptor alpha agonist includes increased expression of proteome maintenance genes. J. Biol. Chem. 2004, 279:52390-52398.
11. Matthay M.A., Zimmerman G.A., Esmon C., Bhattacharya J., Coller B., Doerschuk C.M., Floros J., Gimbrone M.A., Hoffman E., Hubmayr R.D., Leppert M., Matalon S., Munford R., Parsons P., Slutsky A.S., Tracey K.J., Ward P., Gail D.B., Harabin A.L. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am. J. Respir. Crit. Care Med. 2003, 167:1027-1035.
12. Delayre-Orthez C., Becker J., Guenon I., Lagente V., Auwerx J., Frossard N., Pons F. PPARalpha downregulates airway inflammation induced by lipopolysaccharide in the mouse. Respir. Res. 2005, 6:91.
13. Meduri G.U., Kohler G., Headley S., Tolley E., Stentz F., Postlethwaite A. Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome. Chest 1995, 108:1303-1314.
14. Shenkar R., Coulson W.F., Abraham E. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am. J. Respir. Cell Mol. Biol. 1994, 10:290-297.
15. Miller D.L., Welty-Wolf K., Carraway M.S., Ezban M., Ghio A., Suliman H., Piantadosi C.A. Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 2002, 26:650-658.
16. Zhang M.A., Rego D., Moshkova M., Kebir H., Chruscinski A., Nguyen H., Akkermann R., Stanczyk F.Z., Prat A., Steinman L., Dunn S.E. Peroxisome proliferator-activated receptor (PPAR)alpha and -gamma regulate IFNgamma and IL-17A production by human T cells in a sex-specific way. Proc. Natl. Acad. Sci. U.S.A 2012, 109:9505-9510.
17. Haddad I.Y., Pataki G., Hu P., Galliani C., Beckman J.S., Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest. 1994, 94:2407-2413.
18. Bhandari V., Johnson L., Smith-Kirwin S., Vigliotta G., Funanage V., Chander A. Hyperoxia and nitric oxide reduce surfactant components (DSPC and surfactant proteins) and increase apoptosis in adult and fetal rat type II pneumocytes. Lung 2002, 180:301-317.